LUMOSA THERAPEUTICS CO LTD(TW:6535)
NT$80.80+7.30 (+9.93%)
TW:6535
LUMOSA THERAPEUTICS CO LTD financials statements
NT$80.80
At close:+7.30 (+9.93%)
LUMOSA THERAPEUTICS CO LTD (6535) Financial Statements
LUMOSA THERAPEUTICS CO LTD Financial Overview
LUMOSA THERAPEUTICS CO LTD's market cap is currently NT$12.33B. The company's EPS TTM is NT$-2.23; its P/E ratio is -33.67; LUMOSA THERAPEUTICS CO LTD has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 35.83M | NT$ 39.15M | NT$ 56.92M | NT$ 26.64M | NT$ 17.36M |
| Gross Profit | NT$ 21.87M | NT$ 17.71M | NT$ 41.48M | NT$ 14.56M | NT$ 9.89M |
| Operating Income | NT$ -333.49M | NT$ -356.94M | NT$ -375.63M | NT$ -305.92M | NT$ -430.28M |
| EBITDA | NT$ -322.23M | NT$ -428.24M | NT$ -226.68M | NT$ -482.13M | NT$ 128.31M |
| Net Income | NT$ -346.62M | NT$ -424.78M | NT$ -238.04M | NT$ -494.66M | NT$ 95.95M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 798.34M | NT$ 1.35B | NT$ 844.31M | NT$ 1.18B | NT$ 1.45B |
| Total Assets | NT$ 1.65B | NT$ 2.13B | NT$ 1.66B | NT$ 1.89B | NT$ 2.35B |
| Total Debt | NT$ 6.92M | NT$ 8.48M | NT$ 12.61M | NT$ 4.69M | NT$ 11.49M |
| Net Debt | NT$ -174.67M | NT$ -227.01M | NT$ -412.64M | NT$ -512.16M | NT$ -828.83M |
| Total Liabilities | NT$ 131.04M | NT$ 205.46M | NT$ 227.69M | NT$ 215.72M | NT$ 230.11M |
| Stockholders' Equity | NT$ 1.51B | NT$ 1.91B | NT$ 1.40B | NT$ 1.63B | NT$ 2.12B |
| Cash Flow | |||||
| Free Cash Flow | NT$ -357.07M | NT$ -296.78M | NT$ -343.23M | NT$ -302.74M | NT$ -453.18M |
| Operating Cash Flow | NT$ -356.41M | NT$ -296.33M | NT$ -328.21M | NT$ -300.46M | NT$ -452.60M |
| Investing Cash Flow | NT$ 366.10M | NT$ -787.10M | NT$ 240.58M | NT$ -69.20M | NT$ -36.98M |
| Financing Cash Flow | NT$ -63.59M | NT$ 893.62M | NT$ -3.94M | NT$ 46.17M | NT$ 431.28M |
Currency in TWD
